Save your place

Sign in to WhoBought

Please try again later.

Ken Griffin's CVS Health Corp. (CVS) position

Yes: as of Q1 2026, Ken Griffin holds 5.4M shares of CVS worth $390M (0.3% of the disclosed portfolio). Held since at least Q1 2021; that opening coverage snapshot is not counted as a purchase.
View full portfolio →
Current value
$390M
Shares held
5.4M
% of portfolio
0.3%
Est. average buy price (i)
$66.66
est. since Q1 2021
Quarter-end price
$71.82

Estimated trade prices

Average price in quarters with purchases
$69.73
Average prices in quarters with sales
  • Q3 2025: $68.53 (5.0M shares sold)
  • Q1 2025: $59.84 (106K shares sold)
  • Q1 2024: $76.39 (1.5M shares sold)
  • Q2 2023: $71.15 (438K shares sold)
  • Q4 2022: $96.49 (650K shares sold)
  • Q1 2022: $105.05 (1.1M shares sold)
  • Q3 2021: $83.76 (755K shares sold)
  • Q2 2021: $81.89 (321K shares sold)

CVS price vs Griffin's position

1Y 3Y 5Y MAX
Dates
$40$100$15020222023202420252026Sold 755K shares (86.3%) · Q3 2021. Average closing price $83.76 · Price range $80.05–$87.47755KsharessoldAdded 1.1M shares (903.4%) · Q4 2021. Average closing price $92.41 · Price range $83.15–$103.701.1MsharespurchasedSold 1.1M shares (92.4%) · Q1 2022. Average closing price $105.05 · Price range $100.77–$110.831.1MsharessoldAdded 934K shares (over 1,000%) · Q2 2022. Average closing price $97.60 · Price range $88.66–$106.64934KsharespurchasedAdded 430K shares (42.0%) · Q3 2022. Average closing price $98.99 · Price range $92.53–$106.43430KsharespurchasedSold 650K shares (44.7%) · Q4 2022. Average closing price $96.49 · Price range $87.84–$103.79650KsharessoldAdded 523K shares (65.0%) · Q1 2023. Average closing price $83.85 · Price range $72.37–$92.91523KsharespurchasedSold 438K shares (33.0%) · Q2 2023. Average closing price $71.15 · Price range $66.65–$77.75438KsharessoldAdded 286K shares (32.2%) · Q3 2023. Average closing price $70.86 · Price range $65.17–$76.41286KsharespurchasedAdded 472K shares (40.2%) · Q4 2023. Average closing price $71.17 · Price range $66.29–$79.00472KsharespurchasedSold 1.5M shares (91.9%) · Q1 2024. Average closing price $76.39 · Price range $71.99–$81.421.5MsharessoldAdded 10K shares (7.4%) · Q2 2024. Average closing price $62.55 · Price range $53.63–$79.5610KsharespurchasedAdded 2.0M shares (over 1,000%) · Q3 2024. Average closing price $58.34 · Price range $55.81–$63.182.0MsharespurchasedAdded 4.2M shares (194.2%) · Q4 2024. Average closing price $56.10 · Price range $43.78–$67.464.2MsharespurchasedSold 106K shares (1.7%) · Q1 2025. Average closing price $59.84 · Price range $44.22–$68.64106KsharessoldAdded 1.9M shares (30.6%) · Q2 2025. Average closing price $65.57 · Price range $60.04–$70.181.9MsharespurchasedSold 5.0M shares (60.7%) · Q3 2025. Average closing price $68.53 · Price range $58.75–$76.505.0MsharessoldAdded 384K shares (11.9%) · Q4 2025. Average closing price $78.87 · Price range $75.00–$83.04384KsharespurchasedAdded 1.8M shares (50.7%) · Q1 2026. Average closing price $77.05 · Price range $70.14–$83.871.8Msharespurchased← Earlier —1 sell
Average closing price · filing quarter
$77.05
Price range · filing quarter
$70.14 – $83.87
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Added +1.8M +$141M +50.7% 5.4M May 15, 2026
Q4 2025 Added +384K +$30M +11.9% 3.6M Feb 17, 2026
Q3 2025 Reduced −5.0M −$340M −60.7% 3.2M Nov 14, 2025
Q2 2025 Added +1.9M +$126M +30.6% 8.2M Aug 14, 2025
Q1 2025 Reduced −106K −$6.4M −1.7% 6.3M May 15, 2025
Q4 2024 Added +4.2M +$236M +194.2% 6.4M Feb 14, 2025
Q3 2024 Added +2.0M +$118M +1,401.7% 2.2M Nov 14, 2024
Q2 2024 Added +10K +$620K +7.4% 144K Aug 14, 2024
Q1 2024 Reduced −1.5M −$116M −91.9% 134K May 15, 2024
Q4 2023 Added +472K +$34M +40.2% 1.6M Feb 14, 2024
Q3 2023 Added +286K +$20M +32.2% 1.2M Nov 14, 2023
Q2 2023 Reduced −438K −$31M −33.0% 890K Aug 14, 2023
Q1 2023 Added +523K +$44M +65.0% 1.3M May 15, 2023
Q4 2022 Reduced −650K −$63M −44.7% 805K Feb 14, 2023
Q3 2022 Added +430K +$43M +42.0% 1.5M Nov 14, 2022
Q2 2022 Added +934K +$91M +1,028.5% 1.0M Aug 15, 2022
Q1 2022 Reduced −1.1M −$117M −92.4% 91K May 16, 2022
Q4 2021 Added +1.1M +$100M +903.4% 1.2M Feb 14, 2022
Q3 2021 Reduced −755K −$63M −86.3% 120K Nov 15, 2021
Q2 2021 Reduced −321K −$26M −26.8% 875K Aug 16, 2021
Q1 2021 First covered – – – 1.2M May 21, 2021
Data through Q1 2026 · filed May 15, 2026
21 grouped rows from 21 quarters

More Griffin positions

NVIDIA Corporation(NVDA)
$3.2B
2.3% of portfolio

Amazon.com, Inc.(AMZN)
$1.7B
1.2% of portfolio

Micron Technology, Inc.(MU)
$1.6B
1.1% of portfolio

Taiwan Semiconductor Manufacturing Company Limited(TSM)
$1.4B
1.0% of portfolio

Apple Inc.(AAPL)
$1.3B
0.9% of portfolio

Meta Platforms, Inc.(META)
$1.0B
0.7% of portfolio

Common questions

Does Ken Griffin own CVS?

Yes. As of Q1 2026, Ken Griffin disclosed 5.4M shares of CVS, worth $390M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Ken Griffin buy CVS?

Ken Griffin held CVS since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Ken Griffin sell CVS?

The quarter-by-quarter table above shows each sale and reduction Ken Griffin disclosed in CVS. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of CVS does Ken Griffin own?

Ken Griffin disclosed 5.4M shares of CVS as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Ken Griffin pay for CVS?

Ken Griffin began building the CVS position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.